Deep sequencing identifies circulating mouse miRNAs that are functionally implicated in manifestations of aging and responsive to calorie restriction

Aging

Volumn 5, Issue 2, 2013, Pages 130-141

  Dhahbi, Joseph M ^a,c   Spindler, Stephen R ^a   Atamna, Hani ^b   Yamakawa, Amy ^a   Guerrero, Noel ^a   Boffelli, Dario ^c   Mote, Patricia ^a   Martin, David I K ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Janet Weis Children s Hospital   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Aging; Calorie restriction; Circulating miRNAs; Serum; Small RNAs

Indexed keywords

EID: 84874953395     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100540     Document Type: Article

References (69)

1. Djuranovic S, Nahvi A and Green R. A parsimonious model for gene regulation by miRNAs. Science. 2011; 331:550-553.
2. Fabian MR, Sonenberg N and Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annual review of biochemistry. 2010; 79:351-379.
3. Friedman RC, Farh KK, Burge CB and Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome research. 2009; 19:92-105.
4. Heinrich EM and Dimmeler S. MicroRNAs and stem cells: control of pluripotency, reprogramming, and lineage commitment. Circulation research. 2012; 110:1014-1022.
5. Ivey KN and Srivastava D. MicroRNAs as regulators of differentiation and cell fate decisions. Cell stem cell. 2010; 7:36-41.
6. Iorio MV and Croce CM. microRNA involvement in human cancer. Carcinogenesis. 2012; 33:1126-1133.
7. Koturbash I, Zemp FJ, Pogribny I and Kovalchuk O. Small molecules with big effects: the role of the microRNAome in cancer and carcinogenesis. Mutation research. 2011; 722:94-105.
8. Avraham R and Yarden Y. Regulation of signalling by microRNAs. Biochemical Society transactions. 2012; 40:26-30.
9. Ichimura A, Ruike Y, Terasawa K and Tsujimoto G. miRNAs and regulation of cell signaling. The FEBS journal. 2011; 278:1610- 1618.
10. Sheinerman KS, Tsivinsky VG, Crawford F, Mullan MJ, Abdullah L and Umansky SR. Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging. 2012; 4:590-605.
11. Provost P. Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases. Aging. 2010; 2:166-169.
12. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD and Remaley AT. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature cell biology. 2011; 13:423-433.
13. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, Mitchell PS, Bennett CF, Pogosova-Agadjanyan EL, Stirewalt DL, Tait JF and Tewari M. 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America, pp. 5003-5008.
14. Turchinovich A and Burwinkel B. Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA biology. 2012; 9:1066-1075.
15. Vickers KC and Remaley AT. Lipid-based carriers of microRNAs and intercellular communication. Current opinion in lipidology. 2012; 23:91-97.
16. Shah MY and Calin GA. The Mix of Two Worlds: Non-Coding RNAs and Hormones. Nucleic acid therapeutics. 2013; 23:2-8
17. Turchinovich A, Weiz L and Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends in biochemical sciences. 2012; 37:460-465.
18. Salic K and De Windt LJ. MicroRNAs as biomarkers for myocardial infarction. Current atherosclerosis reports. 2012; 14:193-200.
19. Xu J, Zhao J, Evan G, Xiao C, Cheng Y and Xiao J. Circulating microRNAs: novel biomarkers for cardiovascular diseases. J Mol Med (Berl). 2012; 90:865-875.
20. Filkova M, Jungel A, Gay RE and Gay S. MicroRNAs in rheumatoid arthritis: potential role in diagnosis and therapy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 2012; 26:131-141.
21. Zampetaki A, Willeit P, Drozdov I, Kiechl S and Mayr M. Profiling of circulating microRNAs: from single biomarkers to rewired networks. Cardiovascular research. 2012; 93:555-562.
22. Lehmann SM, Kruger C, Park B, Derkow K, Rosenberger K, Baumgart J, Trimbuch T, Eom G, Hinz M, Kaul D, Habbel P, Kalin R, Franzoni E, et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nature neuroscience. 2012; 15:827-835.
23. Spindler SR and Dhahbi JM. Conserved and tissue-specific genic and physiologic responses to caloric restriction and altered IGFI signaling in mitotic and postmitotic tissues. Annual review of nutrition. 2007; 27:193-217.
24. Dhahbi JM, Kim HJ, Mote PL, Beaver RJ and Spindler SR. Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101:5524-5529.
25. Cao SX, Dhahbi JM, Mote PL and Spindler SR. Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proceedings of the National Academy of Sciences of the United States of America. 2001; 98:10630-10635.
26. Lee CK, Klopp RG, Weindruch R and Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science. 1999; 285:1390-1393.
27. Lee CK, Weindruch R and Prolla TA. Gene-expression profile of the ageing brain in mice. Nature genetics. 2000; 25:294-297.
28. Weindruch R, Kayo T, Lee CK and Prolla TA. Microarray profiling of gene expression in aging and its alteration by caloric restriction in mice. The Journal of nutrition. 2001; 131:918S- 923S.
29. Spindler SR. Caloric restriction: from soup to nuts. Ageing research reviews. 2010; 9:324-353.
30. McCay CM, Crowell MF and Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition. 1989; 5:155-171; discussion 172.
31. Boehm M and Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science. 2005; 310:1954-1957.
32. Smith-Vikos T and Slack FJ. MicroRNAs and their roles in aging. Journal of cell science. 2012; 125:7-17.
33. ElSharawy A, Keller A, Flachsbart F, Wendschlag A, Jacobs G, Kefer N, Brefort T, Leidinger P, Backes C, Meese E, Schreiber S, Rosenstiel P, Franke A, et al. Genome-wide miRNA signatures of human longevity. Aging cell. 2012; 11:607-616.
34. Noren Hooten N, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB and Evans MK. microRNA expression patterns reveal differential expression of target genes with age. PloS one. 2010; 5:e10724.
35. Hackl M, Brunner S, Fortschegger K, Schreiner C, Micutkova L, Muck C, Laschober GT, Lepperdinger G, Sampson N, Berger P, Herndler-Brandstetter D, Wieser M, Kuhnel H, et al. miR-17, miR-19b, miR-20a, and miR-106a are down-regulated in human aging. Aging cell. 2010; 9:291-296.
36. Grillari J and Grillari-Voglauer R. Novel modulators of senescence, aging, and longevity: Small non-coding RNAs enter the stage. Experimental gerontology. 2010; 45:302-311.
37. Xu D and Tahara H. The role of exosomes and microRNAs in senescence and aging. Advanced drug delivery reviews. 2012. Jul 20. [Epub ahead of print].
38. Liang R, Bates DJ and Wang E. Epigenetic Control of MicroRNA Expression and Aging. Current genomics. 2009; 10:184-193.
39. Marasa BS, Srikantan S, Martindale JL, Kim MM, Lee EK, Gorospe M and Abdelmohsen K. MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging. 2010; 2:333-343.
40. Dhahbi JM, Atamna H, Boffelli D, Magis W, Spindler SR and Martin DI. Deep sequencing reveals novel microRNAs and regulation of microRNA expression during cell senescence. PloS one. 2011; 6:e20509.
41. Bhaumik D, Scott GK, Schokrpur S, Patil CK, Orjalo AV, Rodier F, Lithgow GJ and Campisi J. MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL- 6 and IL-8. Aging. 2009; 1:402-411.
42. Mancini M, Saintigny G, Mahe C, Annicchiarico-Petruzzelli M, Melino G and Candi E. MicroRNA-152 and -181a participate in human dermal fibroblasts senescence acting on cell adhesion and remodeling of the extra-cellular matrix. Aging. 2012; 4:843- 853.
43. Marino G, Ugalde AP, Fernandez AF, Osorio FG, Fueyo A, Freije JM and Lopez-Otin C. Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107:16268-16273.
44. Khanna A, Muthusamy S, Liang R, Sarojini H and Wang E. Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice. Aging. 2011; 3:223-236.
45. Li X, Khanna A, Li N and Wang E. Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging. Aging. 2011; 3:985-1002.
46. Olivieri F, Spazzafumo L, Santini G, Lazzarini R, Albertini MC, Rippo MR, Galeazzi R, Abbatecola AM, Marcheselli F, Monti D,Ostan R, Cevenini E, Antonicelli R, et al. Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging. Mechanisms of ageing and development. 2012; 133:675-685.
47. Friedlander MR, Mackowiak SD, Li N, Chen W and Rajewsky N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic acids research. 2012; 40:37-52.
48. Robinson MD, McCarthy DJ and Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010; 26:139-140.
49. Geekiyanage H, Jicha GA, Nelson PT and Chan C. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Experimental neurology. 2012; 235:491-496.
50. Wang X and El Naqa IM. Prediction of both conserved and nonconserved microRNA targets in animals. Bioinformatics. 2008; 24:325-332.
51. Mi H, Muruganujan A and Thomas PD. PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic acids research. 2013; 41:D377-386.
52. Huang da W, Sherman BT and Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols. 2009; 4:44-57.
53. Kirkwood TB and Austad SN. Why do we age? Nature. 2000; 408:233-238.
54. Pollack M, Phaneuf S, Dirks A and Leeuwenburgh C. The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Annals of the New York Academy of Sciences. 2002; 959:93-107.
55. Wang C, Sinha Hikim AP, Lue YH, Leung A, Baravarian S and Swerdloff RS. Reproductive aging in the Brown Norway rat is characterized by accelerated germ cell apoptosis and is not altered by luteinizing hormone replacement. Journal of andrology. 1999; 20:509-518.
56. Higami Y and Shimokawa I. Apoptosis in the aging process. Cell and tissue research. 2000; 301:125-132.
57. Hursting SD, Lavigne JA, Berrigan D, Perkins SN and Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annual review of medicine. 2003; 54:131-152.
58. Muskhelishvili L, Turturro A, Hart RW and James SJ. Pi-class glutathione-S-transferase-positive hepatocytes in aging B6C3F1 mice undergo apoptosis induced by dietary restriction. The American journal of pathology. 1996; 149:1585-1591.
59. Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, Wagner A, Lauer B and Schulte-Hermann R. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proceedings of the National Academy of Sciences of the United States of America. 1994; 91:9995-9999.
60. Arthur ST and Cooley ID. The effect of physiological stimuli on sarcopenia; impact of Notch and Wnt signaling on impaired aged skeletal muscle repair. International journal of biological sciences. 2012; 8:731-760.
61. Lin K, Dorman JB, Rodan A and Kenyon C. daf-16: An HNF- 3/forkhead family member that can function to double the lifespan of Caenorhabditis elegans. Science. 1997; 278(:1319-1322.
62. Yamaza H, Komatsu T, Wakita S, Kijogi C, Park S, Hayashi H, Chiba T, Mori R, Furuyama T, Mori N and Shimokawa I. FoxO1 is involved in the antineoplastic effect of calorie restriction. Aging cell. 2010; 9:372-382.
63. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, et al. MicroRNA expression profiles classify human cancers. Nature. 2005; 435:834-838.
64. Hebert SS and De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends in neurosciences. 2009; 32:199-206.
65. Aw S and Cohen SM. Time is of the essence: microRNAs and age-associated neurodegeneration. Cell research. 2012; 22:1218-1220.
66. Ranjha R and Paul J. Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer. Inflammation research : official journal of the European Histamine Research Society. 2013.
67. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W and Cui Q. An analysis of human microRNA and disease associations. PloS one. 2008; 3:e3420.
68. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, Li M, Wang G and Liu Y. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic acids research. 2009; 37:D98-104.
69. Ruepp A, Kowarsch A, Schmidl D, Buggenthin F, Brauner B, Dunger I, Fobo G, Frishman G, Montrone C and Theis FJ. PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome biology. 2010; 11:R6.